Bio-Rad Laboratories (BIO) Curent Deferred Tax Liability (2013 - 2014)
Bio-Rad Laboratories (BIO) posted quarterly Curent Deferred Tax Liability of $13.8 million for Q2 2014, up 45.49% quarter-over-quarter from $9.5 million in Q4 2013.
Bio-Rad Laboratories (BIO) Curent Deferred Tax Liability (2013 - 2014) Analysis & Trends
Bio-Rad Laboratories (BIO) has reported Curent Deferred Tax Liability for 2 consecutive years, with $13.8 million the latest figure, recorded in Q2 2014.
- In Q2 2014, Curent Deferred Tax Liability changed N/A year-over-year to $13.8 million; the TTM figure through Jun 2014 stood at $13.8 million (changed N/A YoY), while the FY2013 annual figure was $9.5 million, changed N/A from the prior year.
- Curent Deferred Tax Liability advanced to $13.8 million in Q2 2014 per BIO's latest filing, from $9.5 million in the prior quarter.
- Across five years, Curent Deferred Tax Liability topped out at $13.8 million in Q2 2014 and bottomed at $9.5 million in Q4 2013.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Curent Deferred Tax Liability (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | - |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | - |
| 10 | Bio-Rad Laboratories | 10.08 Bn | 8.46 Bn | 345.80 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2014 | 13.76 Mn |
| Jun 30, 2014 | 13.76 Mn |
| Dec 31, 2013 | 9.45 Mn |
| Dec 31, 2013 | 9.45 Mn |